Show simple item record

dc.contributor.authorBarug, Daan
dc.contributor.authorBerbers, Guy A M
dc.contributor.authorvan Houten, Marlies A
dc.contributor.authorKuijer, Marjan
dc.contributor.authorPronk, Inge
dc.contributor.authorKnol, Mirjam J
dc.contributor.authorSanders, Elisabeth A M
dc.contributor.authorRots, Nynke Y
dc.date.accessioned2020-07-09T13:02:07Z
dc.date.available2020-07-09T13:02:07Z
dc.date.issued2020-06-15
dc.identifier.issn1873-2518
dc.identifier.pmid32448624
dc.identifier.doi10.1016/j.vaccine.2020.04.001
dc.identifier.urihttp://hdl.handle.net/10029/623893
dc.language.isoenen_US
dc.subjectDiphtheriaen_US
dc.subjectInterferenceen_US
dc.subjectMaternal Tdap vaccinationen_US
dc.subjectPneumococcal vaccine carrier proteinen_US
dc.subjectTetanusen_US
dc.titleInfant antibody levels following 10-valent pneumococcal-protein D conjugate and DTaP-Hib vaccinations in the first year of life after maternal Tdap vaccination: An open-label, parallel, randomised controlled trial.en_US
dc.typeArticleen_US
dc.identifier.journalVaccine 2020; 38(29):4632-9en_US
dc.source.journaltitleVaccine


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record